Calendar MediciNova, Inc.

Equities

MNOV

US58468P2065

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
1.355 ^USD	+1.88%		-10.86%	-9.67%

Mar. 27	MediciNova, Inc. Receives a Notice of Allowance for a New Patent Covering MN-166 for the Treatment of Macular Injury in Japan	CI
Mar. 12	Medicinova Announces New Data and Results of Mn-166 in Chlorine Gas-Induced Acute Lung Injury Presented At the 63Rd Annual Meeting of the Society of Toxicology	CI

Chart calendar MediciNova, Inc.

784105a8c1.qYmG_vfj6nYWHTRWdrjTjTuWFwP1IXvN-e8ohl2dAZA.--zFto6lhjpjSX0_Hde1uFHkXXmsdTKDybds1wz4a8L449bHmdCgFCNrbQ~725e64e9db108f81db1b32aa9ae9123e

Upcoming events on MediciNova, Inc.

2024-06-02 11:30 am

American Society of Clinical Oncology Meeting - Abstract Number: 2106

Past events on MediciNova, Inc.

2023-11-17 10:30 pm	Society for Neuro Oncology Meeting
2023-06-12	Annual General Meeting
2023-02-15	World Congress of the Society for Brain Mapping and Therapeutics
2022-09-27	Lytham Partners Fall Investor Conference
2022-06-14 04:00 pm	Annual General Meeting
2022-04-28 01:00 pm	B Riley Securities Virtual Neurology & Ophthalmology Conference
2022-03-28 12:00 pm	Maxim Group Virtual Growth Conference
2021-12-06	ALS MND International Symposium
2021-11-11	AASLD The Liver Meeting
2021-10-23	International Atherosclerosis Symposium
2021-09-08	Morgan Stanley Global Healthcare Conference
2021-08-12 07:00 pm	Interim 2021 Earnings Release
2021-07-13 04:30 pm	Ladenburg Thalmann Healthcare Conference
2021-06-23 01:00 pm	Analyst Meeting - Maxim Group LLC
2021-06-16 04:00 pm	Annual General Meeting
2021-05-23	UBS Global Healthcare Conference
2021-05-13 04:30 pm	Q1 2021 Earnings Release
2021-04-29 01:30 pm	B. Riley Neuroscience Conference
2021-03-17 09:00 am	Maxim Emerging Growth Conference
2020-11-12	American Association for the Study of Liver Diseases Meeting

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	4,04 4,01 0.62%	0,00 0,00 -	1,00 1,00 0%	0,00
EBITDA Million USD	Released Forecast Spread	0,00 0,00 -	-14,2 -15,5 8.63%	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-14,0 -15,6 10.06%	-14,2 -15,5 8.3%	-10,2 -12,5 18.21%	-14,6 -15,7 6.53%	-9,90 -11,6 14.65%	-11,3
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-12,9 -14,7 12.05%	-13,9 -14,7 5.63%	-10,1 -12,4 18.31%	-14,1 -15,2 7.46%	-8,57 -10,5 18.4%	-11,3
Net income Million USD	Released Forecast Spread	-12,9 -14,7 11.96%	-13,9 -14,7 5.64%	-10,1 -12,4 18.29%	-14,1 -15,2 7.44%	-8,57 -10,5 18.37%	-11,3
EPS USD	Released Forecast Spread	-0,30 -0,34 11.76%	-0,31 -0,33 6.06%	-0,21 -0,25 17.1%	-0,29 -0,31 4.92%	-0,17 -0,21 19.05%	-0,23
Announcement Date		13/02/20	19/02/21	16/02/22	16/02/23	15/02/24	-

Quarterly results

Fiscal Period	December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	1,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-2,10 -4,39 52.06%	-3,41 -3,87 11.82%	-4,09 -4,33 5.62%	-3,90 -4,20 7.2%	-3,23 -4,25 23.97%	-2,96 -3,50 15.34%	-3,30 -3,70 10.81%	-1,15 -4,00 71.33%	-2,49 -4,20 40.71%	-2,60	-2,80	-2,90	-3,00
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,08 -4,35 52.2%	-3,39 -3,87 12.43%	-4,03 -4,33 7.02%	-3,65 -4,20 13.04%	-3,00 -4,15 27.74%	-2,92 -3,30 11.59%	-2,87 -3,50 17.95%	-0,72 -3,80 80.97%	-2,06 -4,00 48.6%	-2,60	-2,80	-2,90	-3,00
Net income Million USD	Released Forecast Spread	-2,08 -4,35 52.14%	-3,39 -3,87 12.43%	-4,03 -4,33 7.02%	-3,65 -4,20 13.04%	-3,00 -4,15 27.68%	-2,92 -3,30 11.59%	-2,87 -3,50 17.95%	-0,72 -3,80 80.97%	-2,06 -4,00 48.52%	-2,60	-2,80	-2,90	-3,00
EPS USD	Released Forecast Spread	-0,04 -0,09 55.56%	-0,07 -0,08 12.5%	-0,08 -0,09 7.7%	-0,07 -0,09 22.22%	-0,06 -0,09 29.41%	-0,06 -0,07 14.29%	-0,06 -0,07 14.29%	-0,01 -0,08 87.5%	-0,04 -0,08 50%	-0,05	-0,06	-0,06	-0,06
Announcement Date		16/02/22	12/05/22	11/08/22	10/11/22	16/02/23	11/05/23	09/08/23	09/11/23	15/02/24	-	-	-	-

Upcoming sector events for MediciNova, Inc.

Today 06:30 am	SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-28	HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)

More events

Past sector events for MediciNova, Inc.

Today	JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today	BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
Today	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today	REMEGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
Today	HITGEN INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm	VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-23	INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23	SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-23 07:30 am	KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release